Preventive medicine physicians are uniquely trained in both clinical medicine and public health to understand and reduce the risks of disease, disability, and death in individuals and populations. The nation is facing a severe shortage of preventive medicine–trained physicians, which is largely due to unstable and inadequate residency program funding.
Several policy options have been explored and evaluated to fund preventive medicine residency training programs as part of a multipronged approach to engage physicians in the policy-making process.
The most adequate, sustainable, distributable, and politically feasible policy option was pursued, and a bill called the “Preventive Medicine and Public Health Training Act” was introduced into the House and the Senate.
Opportunities to participate in the policy-making process and interact with key legislators and stakeholders exist in a variety of ways. Leadership at the federal level helps preventive medicine and public health physicians recognize their vital role in shaping public policy.
This study emphasizes how federal policy is shaped and how physicians can interact with key legislators and stakeholders.
Assistant Vice President for NanoHealth Initiatives and is Assistant Professor of Nanobioscience, Albany College of Nanoscale Science & Engineering, University at Albany, New York. (Brenner)
Health Economics and Outcomes Research Fellow, Ortho Clinical Diagnostics, Raritan, NJ. (Siu)
Corresponding Author: Sara Brenner, MD, MPH, Albany College of Nanoscale Science & Engineering, University at Albany, 255 Fuller Rd, Albany, NY 12203 (email@example.com).
The American College of Preventive Medicine (ACPM)/Pfizer Practicum Rotation in Health Policy and Preventive Medicine is sponsored by ACPM and Pfizer Inc.